Plus Therapeutics Inc.

11/25/2024 | Press release | Distributed by Public on 11/25/2024 07:00

Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 SNO Annual Conference